Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia. (7th April 2018)

• Record Type: Journal Article
• Authors: Serota, David P; Rosenberg, Eli S; Lockard, Annie M; Rolle, Charlotte-Paige M; Luisi, Nicole; Cutro, Scott; del Rio, Carlos; Siegler, Aaron J; Sanchez, Travis H; Sullivan, Patrick S; Kelley, Colleen F
• Is Part Of: Clinical infectious diseases. Volume 67:Number 6(2018)
• Page Start: 965
• Page End: 970
• Publication Date: 2018-04-07
• Subjects: health disparities -- HIV -- preexposure prophylaxis; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciy297
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract : In a cohort of young black men who have sex with men, we observed high human immunodeficiency virus incidence despite education and access to preexposure prophylaxis (PrEP). Although PrEP has efficacy in clinical trials, we identify barriers to real-world effectiveness. Abstract: Human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) has high biomedical efficacy; however, awareness, access, uptake, and persistence on therapy remain low among black men who have sex with men (BMSM), who are at highest risk of HIV in the United States. To date, discussions of "PrEP failure" have focused on one typology: rare, documented HIV acquisitions among PrEP users with adequate serum drug levels (ie, biomedical failure). In our cohort of HIV-negative young BMSM in Atlanta, Georgia, we continue to observe a high HIV incidence (6.2% annually at interim analysis) despite access to free PrEP services. Among 14 seroconversions, all were offered PrEP before acquiring HIV. Among these participants, we identified 4 additional typologies of PrEP failure that expand beyond biomedical failure: low PrEP adherence, PrEP discontinuation, PrEP contemplation without initiation, and PrEP refusal. We describe the 5 typologies and suggest interventions to improve PrEP effectiveness among those at highest risk.